S100A7蛋白在宫颈鳞癌中的表达分析
Expression Analysis of S100A7 Protein in Cervical Squamous Cell Carcinoma
DOI: 10.12677/ACM.2023.133484, PDF,   
作者: 傅 宏:青岛大学医学部,山东 青岛;崔竹梅*:青岛大学附属医院妇科,山东 青岛
关键词: S100A7蛋白HPV宫颈鳞癌S100A7 Protein HPV Cervical Squamous Carcinoma
摘要: 目的:分析S100A7蛋白的表达量与宫颈鳞癌患者各个临床病理指标之间的关系,探讨该蛋白在宫颈鳞癌中的表达与肿瘤分化、侵袭、转移之间的关系。方法:选取2016年5月至2021年4月因宫颈鳞癌在青岛大学附属医院妇科行手术切除的标本49例,采用免疫组化的方法,对S100A7蛋白进行半定量分析,收集整理宫颈鳞癌患者的临床病理信息,运用统计学方法分析S100A7蛋白表达量与各临床病理参数之间的关系。结果:宫颈鳞癌中,S100A7蛋白的表达量与肿瘤分化、淋巴结转移有关,与发病年龄、肿瘤大小、FIGO分期、脉管转移无关。结论:S100A7蛋白与宫颈鳞癌分化、淋巴结转移有关,S100A7蛋白表达上调可能与宫颈鳞癌发生、进展、侵袭、转移有关。
Abstract: Objective: To analyze the relationship between the expression of S100A7 protein and various clini-copathological indicators in patients with cervical squamous carcinoma, and to explore the rela-tionship between the expression of this protein in cervical squamous carcinoma and tumor differ-entiation, invasion and metastasis. Methods: Forty-nine specimens with surgical resection for cer-vical squamous carcinoma in the Department of Gynecology, Affiliated Hospital of Qingdao Univer-sity were selected from May 2016 to April 2021, and the S100A7 protein was analyzed semi-quantitatively by immunohistochemistry. The clinicopathological information of patients with cervical squamous carcinoma was collected and collated. The relationship between S100A7 protein expression and various clinicopathological parameters was analyzed by using statistical methods. Results: In squamous carcinoma of the cervix, the expression of S100A7 protein was associated with tumor differentiation and lymph node metastasis, but not with age at onset, tumor size, FIGO stage and vascular metastasis. Conclusions: S100A7 protein was associated with cervical squamous car-cinoma differentiation and lymph node metastasis, and up-regulation of S100A7 protein expression may be related to cervical squamous carcinoma occurrence, progression, invasion and metastasis.
文章引用:傅宏, 崔竹梅. S100A7蛋白在宫颈鳞癌中的表达分析[J]. 临床医学进展, 2023, 13(3): 3402-3407. https://doi.org/10.12677/ACM.2023.133484

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Li, L., Jiang, M., Li, T., et al. (2022) Absolute Risk and Attributable Frac-tion of Type-Specific Human Papillomavirus in Cervical Cancer and Precancerous Lesions—A Population-Based Study of 6286 Women in Rural Areas of China. Journal of Clinical Medicine, 11, 6483. [Google Scholar] [CrossRef] [PubMed]
[3] Madsen, P., Rasmussen, H.H., Leffers, H., et al. (1991) Molecular Cloning, Occurrence, and Expression of a Novel Partially Secreted Protein “Psoriasin” That Is Highly Up-Regulated in Psoriatic Skin. Journal of Investigative Dermatology, 97, 701-712. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, H., Xu, C., Jin, Q. and Liu, Z. (2014) S100 Protein Family in Human Cancer. American Journal of Cancer Research, 4, 89-115.
[5] Emberley, E.D., Murphy, L.C. and Watson, P.H. (2004) S100A7 and the Progression of Breast Cancer. Breast Cancer Research, 6, 153-159. [Google Scholar] [CrossRef] [PubMed]
[6] Kesting, M.R., Sudhoff, H., Hasler, R.J., et al. (2009) Psoriasin (S100A7) Up-Regulation in Oral Squamous Cell Carcinoma and Its Relation to Clinicopathologic Features. Oral Oncology, 45, 731-736. [Google Scholar] [CrossRef] [PubMed]
[7] Lu, Z., Zheng, S., Liu, C., et al. (2021) S100A7 as a Po-tential Diagnostic and Prognostic Biomarker of Esophageal Squamous Cell Carcinoma Promotes M2 Macrophage Infil-tration and Angiogenesis. Clinical and Translational Medicine, 11, e459. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, R., Li, Y., Hu, E., et al. (2017) S100A7 Promotes Lung Adenocarci-noma to Squamous Carcinoma Transdifferentiation, and Its Expression Is Differentially Regulated by the Hippo-YAP Pathway in Lung Cancer Cells. Oncotarget, 8, 24804-24814. [Google Scholar] [CrossRef] [PubMed]
[9] Alowami, S., Qing, G., Emberley, E., et al. (2003) Psoriasin (S100A7) Expression Is Altered during Skin Tumorigenesis. BMC Dermatology, 3, Article No. 1. [Google Scholar] [CrossRef] [PubMed]
[10] Leygue, E., Snell, L., Hiller, T., et al. (1996) Differential Expression of Psoriasin Messenger RNA between in Situ and Invasive Human Breast Carcinoma. Cancer Research, 56, 4606-4609.
[11] Qu, Y., Liu, H. and Li, S. (2014) Effects of S100A7 on the Proliferation and Invasiveness of Esopha-geal Squamous Cell Carcinoma EC9706 Cells and Possible Mechanisms. Chinese Medical Journal, 94, 144-147.
[12] Zhang, H., Wang, Y., Chen, Y., et al. (2007) Identification and Validation of S100A7 Associated with Lung Squamous Cell Carcinoma Metastasis to Brain. Lung Cancer, 57, 37-45. [Google Scholar] [CrossRef] [PubMed]
[13] Tian, T., Li, X., Hua, Z., et al. (2017) S100A7 Promotes the Migration, Invasion and Metastasis of Human Cervical Cancer Cells through Epithelial-Mesenchymal Transition. Onco-target, 8, 24964-24977. [Google Scholar] [CrossRef] [PubMed]
[14] Dey, K.K., Sarkar, S., Pal, I., et al. (2015) Mechanistic Attributes of S100A7 (Psoriasin) in Resistance of Anoikis Resulting Tumor Progression in Squamous Cell Carcinoma of the Oral Cavity. Cancer Cell International, 15, 74. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, G., Wu, Q., Liu, G., et al. (2015) Psoriasin (S100A7) Is a Novel Biomarker for Lung Squamous Cell Carcinoma in Humans. Cancer Cell International, 15, 18. [Google Scholar] [CrossRef] [PubMed]